Cargando…
Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders
The objective of this study was to determine whether proteomic profiling in serum samples can be utilized in identifying and differentiating mood disorders. A consecutive sample of patients with a confirmed diagnosis of unipolar (UP n=52) or bipolar depression (BP-I n=46, BP-II n=49) and controls (n...
Autores principales: | Frye, M A, Nassan, M, Jenkins, G D, Kung, S, Veldic, M, Palmer, B A, Feeder, S E, Tye, S J, Choi, D S, Biernacka, J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068585/ https://www.ncbi.nlm.nih.gov/pubmed/26645624 http://dx.doi.org/10.1038/tp.2015.185 |
Ejemplares similares
-
Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders
por: Cabello-Arreola, Alejandra, et al.
Publicado: (2020) -
Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications
por: Veldic, Marin, et al.
Publicado: (2019) -
Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study
por: Ho, Ada Man‐Choi, et al.
Publicado: (2020) -
Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review
por: Gardea-Resendez, Manuel, et al.
Publicado: (2020) -
Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities
por: Prieto, M L, et al.
Publicado: (2016)